LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Home・Aandelen Lijst・Achieve Life Sciences Inc

Achieve Life Sciences Inc

Gesloten

2.9 -3.01

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.83

Max

2.99

Belangrijke statistieken
By Trading Economics
Inkomsten	109K -13M
Winstmarge	-5,421.053
Werknemers	25
EBITDA	-367K -12M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+389.93% upside

Dividenden
By Dow Jones
Volgende Winsten	6 nov 2025

Marktinformatie
By TradingEconomics
Marktkapitalisatie	41M 169M
Vorige openingsprijs	5.91
Vorige sluitingsprijs	2.9

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

2.325 / 2.64 Steun & Weerstand

Achieve Life Sciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 sep 2025, 23:07 UTC

Acquisities, Fusies, Overnames

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 sep 2025, 22:10 UTC

Belangrijke Marktbewegers

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 sep 2025, 21:47 UTC

Winsten

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 sep 2025, 16:52 UTC

Belangrijke Marktbewegers

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 sep 2025, 22:47 UTC

Marktinformatie

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 sep 2025, 21:40 UTC

Acquisities, Fusies, Overnames

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 sep 2025, 21:07 UTC

Winsten

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 sep 2025, 21:07 UTC

Winsten

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q Rev $17.35B >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q EPS 82c >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q Net $782.5M >ATD.T

2 sep 2025, 21:00 UTC

Marktinformatie

ESG Roundup: Market Talk

2 sep 2025, 20:53 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 sep 2025, 20:51 UTC

Acquisities, Fusies, Overnames

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 sep 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

2 sep 2025, 20:27 UTC

Winsten

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 sep 2025, 20:24 UTC

Acquisities, Fusies, Overnames

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 sep 2025, 20:18 UTC

Acquisities, Fusies, Overnames

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 sep 2025, 20:17 UTC

Acquisities, Fusies, Overnames

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 sep 2025, 20:16 UTC

Acquisities, Fusies, Overnames

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 sep 2025, 20:16 UTC

Acquisities, Fusies, Overnames

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 sep 2025, 20:15 UTC

Acquisities, Fusies, Overnames

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 sep 2025, 19:55 UTC

Winsten

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 sep 2025, 19:50 UTC

Acquisities, Fusies, Overnames

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 sep 2025, 19:09 UTC

Marktinformatie

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 sep 2025, 19:00 UTC

Marktinformatie

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 sep 2025, 18:12 UTC

Marktinformatie

Gold Pushes To New Record -- Market Talk

2 sep 2025, 17:04 UTC

Marktinformatie

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 sep 2025, 16:57 UTC

Acquisities, Fusies, Overnames

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Peer Vergelijking

Prijswijziging

Achieve Life Sciences Inc Prognose

Koersdoel

By TipRanks

389.93% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 14.6 USD 389.93%

Hoogste 20 USD

Laagste 10 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Achieve Life Sciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

Buy

Hold

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Achieve Life Sciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

2.325 / 2.64Steun & Weerstand

Recent bullish events outweigh bearish events.

There is one bearish event.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.